Patients with elevated levels of HKDC1 exhibited reduced immune scores and stromal scores, indicating that HKDC1 overexpression hampers the infiltration of immune cells in pancreatic cancer, thereby impeding its anti-tumor effects. The gene discussed is HKDC1; the disease is pancreatic neoplasm.